Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma.
Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma.
复制标题
DOI:
10.1097/coc.0b013e31829378f9
复制
发表时间:
2015-06
期刊:
影响因子:
--
通讯作者:
Guadagnolo BA
中科院分区:
文献类型:
--
作者:
Huo J;Du XL;Lairson DR;Chan W;Jiang J;Buchholz TA;Guadagnolo BA
To examine the patterns of utilization of radiation therapy, chemotherapy, surgery, and hospice at the end of life-care for patients diagnosed with metastatic melanoma. We identified 816 Medicare beneficiaries 65 years of age or older with pathologically confirmed metastatic malignant melanoma between January 1, 2000 and December 31, 2007. We evaluated trends and associations between sociodemographic and health services characteristics and the use of hospice care, chemotherapy, surgery, and radiation therapy. We found increasing use of surgery for patients with metastatic melanoma from 13% in 2000 to 30% in 2007 (P=0.03 for trend), no significant fluctuation in use of chemotherapy (P=0.43) or radiation therapy (P=0.46). Older patients were less likely to receive radiation therapy or chemotherapy. The use of hospice care increased from 61% in 2000 to 79% in 2007 (P =0.07 for trend). Enrollment in short-term (1–3 days) hospice care use increased, while long-term hospice care (≥ 4 days) remained stable. Patients living in the SEER Northeast and South regions were less likely to undergo surgery. Patients enrolled in long-term hospice care used significantly less chemotherapy, surgery and radiation therapy. Surgery and hospice care use increased over the years of this study while the use of chemotherapy and radiation therapy remained consistent for patients diagnosed with metastatic melanoma.